Q4 Do you think it is important for legislation to control advertising of ecigarettes in the same way as it controls advertising of smoked tobacco products? Yes No Reasons/additional comments: Controls on advertising of e-cigarettes will help to prevent uptake of vaping among non-smokers. However, we recommend that regulations still allow the provision of generic information to clients about e-cigarettes by smoking cessation service providers. Q5 Do you it is important for the SFEA to prohibit vaping in designated smokefree areas in the same way as it prohibits smoking in such areas? Yes No Reasons/additional comments: We think it is important for the SFEA to prohibit vaping in designated smokefree areas. Doing so will not disadvantage e-cigarette users relative to tobacco smokers. Not to do so would undermine smokefree legislation and risk re-normalising tobacco smoking. Q6 Do you agree that other controls in the SFEA for smoked tobacco products should apply to ecigarettes? For example: Control Yes No Reasons/ additional comments While graphic warnings are not yet indicated, we submit that there should be a written warning on e-cigarette packaging that the long-term health Requirement for graphic health warnings risks of e-cigarette use are unknown; and also that nicotine can cause acute poisoning with excessive use. Consistent with regulations for tobacco Prohibition on displaying products in sales products. outlets Consistent with regulations for tobacco Restriction on use of vending machines products. This would help to inform research and Requirement to provide annual returns on data future policy reviews. Essential for enabling informed Requirement to disclose product content and composition choices by consumers. Essential for reduction of nicotine Regulations concerning ingredients (e.g. poisoning risk, and for any other nicotine content and/or flavours) potentially harmful ingredients. Independent testing at manufacturers’ Requirement for annual testing of product composition expense. Consistent with regulations for tobacco Prohibition on free distribution and awards associated with sales products.
Q4 Do you think it is important for legislation to control advertising of ecigarettes in the same way as it controls advertising of smoked tobacco products? Yes No Reasons/additional comments: Controls on advertising of e-cigarettes will help to prevent uptake of vaping among non-smokers. However, we recommend that regulations still allow the provision of generic information to clients about e-cigarettes by smoking cessation service providers. Q5 Do you it is important for the SFEA to prohibit vaping in designated smokefree areas in the same way as it prohibits smoking in such areas? Yes No Reasons/additional comments: We think it is important for the SFEA to prohibit vaping in designated smokefree areas. Doing so will not disadvantage e-cigarette users relative to tobacco smokers. Not to do so would undermine smokefree legislation and risk re-normalising tobacco smoking. Q6 Do you agree that other controls in the SFEA for smoked tobacco products should apply to ecigarettes? For example: Control Yes No Reasons/ additional comments Requirement for graphic health warnings While graphic warnings are not yet indicated, we submit that there should be a written warning on e-cigarette packaging that the long-term health risks of e-cigarette use are unknown; and also that nicotine can cause acute poisoning with excessive use. Prohibition on displaying products in sales outlets Consistent with regulations for tobacco products. Restriction on use of vending machines Consistent with regulations for tobacco products. Requirement to provide annual returns on data This would help to inform research and future policy reviews. Requirement to disclose product content and composition Essential for enabling informed choices by consumers. Regulations concerning ingredients (e.g. nicotine content and/or flavours) Essential for reduction of nicotine poisoning risk, and for any other potentially harmful ingredients. Requirement for annual testing of product composition Independent testing at manufacturers’ expense. Prohibition on free distribution and awards associated with sales Consistent with regulations for tobacco products.